Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

15.24
+0.59004.03%
Post-market: 15.300.0600+0.39%19:58 EDT
Volume:1.57M
Turnover:23.80M
Market Cap:1.81B
PE:-13.16
High:15.58
Open:14.75
Low:14.74
Close:14.65
Loading ...

Arcutis Shares Climb on Strong Product Revenue Estimates

Dow Jones
·
13 Jan

Arcutis Biotherapeutics Price Target Maintained With a $19.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Jan

Arcutis Biotherapeutics’ Robust Revenue Growth and Strategic Financial Positioning Underpin Buy Rating

TIPRANKS
·
13 Jan

Arcutis Biotherapeutics: Strong Sales and Strategic Growth Drive Buy Rating

TIPRANKS
·
13 Jan

Arcutis Biotherapeutics Expects Fiscal Q4 Revenue to Soar Driven by Zoryve Demand

MT Newswires Live
·
13 Jan

Strong Financial Performance and Growth Prospects Drive Buy Rating for Arcutis Biotherapeutics

TIPRANKS
·
13 Jan

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hologic (HOLX) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
13 Jan

Arcutis Announces Preliminary Unaudited Fourth Quarter Product Revenue and Full-Year 2024 Product Revenues of Approximately $63 Million and $160 Million

THOMSON REUTERS
·
12 Jan

High Growth Tech Stocks In The United States To Watch

Simply Wall St.
·
10 Jan

Arcutis Biotherapeutics Is Maintained at Outperform by Mizuho

Dow Jones
·
08 Jan

U.S. RESEARCH ROUNDUP-CNX Resources, Inari Medical, Royal Gold

Reuters
·
07 Jan

Arcutis Biotherapeutics (ARQT) Gets a Buy from Mizuho Securities

TIPRANKS
·
07 Jan

BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
07 Jan

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
07 Jan

Here's Why Arcutis Stock More Than Doubled in Market Value in One Year

Zacks
·
04 Jan

Is Arcutis Biotherapeutics (NASDAQ:ARQT) A Risky Investment?

Simply Wall St.
·
02 Jan

HC Wainwright Initiates Arcutis Biotherapeutics at Buy With $19 Price Target

MT Newswires Live
·
30 Dec 2024

U.S. RESEARCH ROUNDUP- Arcutis Biotherapeutics, Artiva Biotherapeutics, Nuvalent

Reuters
·
30 Dec 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks
·
26 Dec 2024

Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX), Arcutis Biotherapeutics (ARQT) and Viking Therapeutics (VKTX)

TIPRANKS
·
25 Dec 2024